Literature DB >> 33276630

The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues.

Lauriane Y M Michel1, Charlotte Farah1, Jean-Luc Balligand1,2.   

Abstract

The third isotype of beta-adrenoreceptors (β3-AR) has recently come (back) into focus after the observation of its expression in white and beige human adipocytes and its implication in metabolic regulation. This coincides with the recent development and marketing of agonists at the human receptor with superior specificity. Twenty years ago, however, we and others described the expression of β3-AR in human myocardium and its regulation of contractility and cardiac remodeling. Subsequent work from many laboratories has since expanded the characterization of β3-AR involvement in many aspects of cardiovascular physio(patho)logy, justifying the present effort to update current paradigms under the light of the most recent evidence.

Entities:  

Keywords:  adrenergic receptor; beige adipocyte; beta; cardiac physiology; catecholamines; heart failure; metabolism; myocardial remodeling

Mesh:

Substances:

Year:  2020        PMID: 33276630      PMCID: PMC7761574          DOI: 10.3390/cells9122584

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  119 in total

Review 1.  Adrenoceptors in white, brown, and brite adipocytes.

Authors:  Bronwyn A Evans; Jon Merlin; Tore Bengtsson; Dana S Hutchinson
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

2.  Beneficial Metabolic Effects of Mirabegron In Vitro and in High-Fat Diet-Induced Obese Mice.

Authors:  Lei Hao; Sheyenne Scott; Mehrnaz Abbasi; Yujiao Zu; Md Shahjalal Hossain Khan; Yang Yang; Dayong Wu; Ling Zhao; Shu Wang
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

3.  Functional beta3-adrenoceptor in the human heart.

Authors:  C Gauthier; G Tavernier; F Charpentier; D Langin; H Le Marec
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.

Authors:  C Gauthier; G Tavernier; J N Trochu; V Leblais; K Laurent; D Langin; D Escande; H Le Marec
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

5.  Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.

Authors:  An L Moens; Jordan S Leyton-Mange; Xiaolin Niu; Ronghua Yang; Oscar Cingolani; Elisabeth K Arkenbout; Hunter C Champion; Djahida Bedja; Kathleen L Gabrielson; Juan Chen; Yong Xia; Ashley B Hale; Keith M Channon; Marc K Halushka; Norman Barker; Floris L Wuyts; Pawel M Kaminski; Michael S Wolin; David A Kass; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

6.  Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals.

Authors:  Naresh C Bal; Santosh K Maurya; Danesh H Sopariwala; Sanjaya K Sahoo; Subash C Gupta; Sana A Shaikh; Meghna Pant; Leslie A Rowland; Eric Bombardier; Sanjeewa A Goonasekera; A Russell Tupling; Jeffery D Molkentin; Muthu Periasamy
Journal:  Nat Med       Date:  2012-09-09       Impact factor: 53.440

7.  Targeting Cardiac Myocyte Na+-K+ Pump Function With β3 Adrenergic Agonist in Rabbit Model of Severe Congestive Heart Failure.

Authors:  Natasha A S Fry; Chia-Chi Liu; Alvaro Garcia; Elisha J Hamilton; Keyvan Karimi Galougahi; Yeon Jae Kim; David W Whalley; Henning Bundgaard; Helge H Rasmussen
Journal:  Circ Heart Fail       Date:  2020-08-26       Impact factor: 8.790

8.  Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial.

Authors:  Ines Garcia-Lunar; Isabel Blanco; Leticia Fernández-Friera; Susanna Prat-Gonzàlez; Paloma Jordà; Javier Sánchez; Daniel Pereda; Sandra Pujadas; Mercedes Rivas; Eduard Solé-Gonzalez; Jorge Vázquez; Zorba Blázquez; Juan García-Picart; Pedro Caravaca; Noemí Escalera; Pablo Garcia-Pavia; Juan Delgado; Javier Segovia-Cubero; Valentín Fuster; Eulalia Roig; Joan Albert Barberá; Borja Ibanez; Ana García-Álvarez
Journal:  JACC Basic Transl Sci       Date:  2020-03-11

9.  Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).

Authors:  Anne-Catherine Pouleur; Stefan Anker; Dulce Brito; Oana Brosteanu; Dirk Hasenclever; Barbara Casadei; Frank Edelmann; Gerasimos Filippatos; Damien Gruson; Ignatios Ikonomidis; Renaud Lhommel; Masliza Mahmod; Stefan Neubauer; Alexandre Persu; Bernhard L Gerber; Stefan Piechnik; Burkert Pieske; Elisabeth Pieske-Kraigher; Fausto Pinto; Piotr Ponikowski; Michele Senni; Jean-Noël Trochu; Nancy Van Overstraeten; Rolf Wachter; Jean-Luc Balligand
Journal:  ESC Heart Fail       Date:  2018-06-22

10.  The Regulator of G Protein Signaling Homologous Domain of G Protein-Coupled Receptor Kinase 2 Mediates Short-Term Desensitization of β3-Adrenergic Receptor.

Authors:  Emiliana Echeverría; Maia Cabrera; Valeria Burghi; Máximo Sosa; Sonia Ripoll; Agustín Yaneff; Federico Monczor; Carlos Davio; Carina Shayo; Natalia Fernández
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

View more
  11 in total

Review 1.  Adrenergic receptors gene polymorphisms and autonomic nervous control of heart and vascular tone.

Authors:  L Matušková; M Javorka
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

2.  The Endothelial Dysfunction Could Be a Cause of Heart Failure with Preserved Ejection Fraction Development in a Rat Model.

Authors:  Thomas Dupas; Thomas Pelé; Justine Dhot; Mélanie Burban; Antoine Persello; Virginie Aillerie; Angélique Erraud; Angela Tesse; David Stevant; Angélique Blangy-Letheule; Céline Menguy; Vincent Sauzeau; Michel De Waard; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Oxid Med Cell Longev       Date:  2022-05-18       Impact factor: 7.310

3.  Remodeling of gene regulatory networks underlying thermogenic stimuli-induced adipose beiging.

Authors:  Seoyeon Lee; Abigail M Benvie; Hui Gyu Park; Roman Spektor; Blaine Harlan; J Thomas Brenna; Daniel C Berry; Paul D Soloway
Journal:  Commun Biol       Date:  2022-06-14

4.  β 3 Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model.

Authors:  Kristen J Bubb; Dhanya Ravindran; Siân P Cartland; Meghan Finemore; Zoe E Clayton; Michael Tsang; Owen Tang; Mary M Kavurma; Sanjay Patel; Gemma A Figtree
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 5.  Therapeutic targets for cardiac fibrosis: from old school to next-gen.

Authors:  Joshua G Travers; Charles A Tharp; Marcello Rubino; Timothy A McKinsey
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

6.  Chronic isoprenaline/phenylephrine vs. exclusive isoprenaline stimulation in mice: critical contribution of alpha1-adrenoceptors to early cardiac stress responses.

Authors:  Matthias Dewenter; Jianyuan Pan; Laura Knödler; Niklas Tzschöckel; Julian Henrich; Julio Cordero; Gergana Dobreva; Susanne Lutz; Johannes Backs; Thomas Wieland; Christiane Vettel
Journal:  Basic Res Cardiol       Date:  2022-03-14       Impact factor: 12.416

Review 7.  Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors.

Authors:  Luca Filippi; Maurizio Cammalleri; Rosario Amato; Massimiliano Ciantelli; Alessandro Pini; Paola Bagnoli; Massimo Dal Monte
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

8.  HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina.

Authors:  Rosario Amato; Francesco Pisani; Emiliano Laudadio; Maurizio Cammalleri; Martina Lucchesi; Silvia Marracci; Luca Filippi; Roberta Galeazzi; Maria Svelto; Massimo Dal Monte; Paola Bagnoli
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

9.  Targeting PLD2 in adipocytes augments adaptive thermogenesis by improving mitochondrial quality and quantity in mice.

Authors:  Hyung Sik Kim; Min Young Park; Nam Joo Yun; Hye Sun Go; Mi Young Kim; Je Kyung Seong; Minyoung Lee; Eun Seok Kang; Jaewang Ghim; Sung Ho Ryu; Brian A Zabel; Ara Koh; Yoe-Sik Bae
Journal:  J Exp Med       Date:  2021-12-23       Impact factor: 17.579

Review 10.  Cardiac Metabolism in Sepsis.

Authors:  Satoshi Kawaguchi; Motoi Okada
Journal:  Metabolites       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.